BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Stein-Thoeringer CK, Nichols KB, Lazrak A, Docampo MD, Slingerland AE, Slingerland JB, Clurman AG, Armijo G, Gomes ALC, Shono Y, Staffas A, Burgos da Silva M, Devlin SM, Markey KA, Bajic D, Pinedo R, Tsakmaklis A, Littmann ER, Pastore A, Taur Y, Monette S, Arcila ME, Pickard AJ, Maloy M, Wright RJ, Amoretti LA, Fontana E, Pham D, Jamal MA, Weber D, Sung AD, Hashimoto D, Scheid C, Xavier JB, Messina JA, Romero K, Lew M, Bush A, Bohannon L, Hayasaka K, Hasegawa Y, Vehreschild MJGT, Cross JR, Ponce DM, Perales MA, Giralt SA, Jenq RR, Teshima T, Holler E, Chao NJ, Pamer EG, Peled JU, van den Brink MRM. Lactose drives Enterococcus expansion to promote graft-versus-host disease. Science 2019;366:1143-9. [PMID: 31780560 DOI: 10.1126/science.aax3760] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 39.0] [Reference Citation Analysis]
Number Citing Articles
1 Riwes M, Reddy P. Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology 2020;57:1-6. [DOI: 10.1053/j.seminhematol.2020.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
2 Peled JU, Gomes ALC, Devlin SM, Littmann ER, Taur Y, Sung AD, Weber D, Hashimoto D, Slingerland AE, Slingerland JB, Maloy M, Clurman AG, Stein-Thoeringer CK, Markey KA, Docampo MD, Burgos da Silva M, Khan N, Gessner A, Messina JA, Romero K, Lew MV, Bush A, Bohannon L, Brereton DG, Fontana E, Amoretti LA, Wright RJ, Armijo GK, Shono Y, Sanchez-Escamilla M, Castillo Flores N, Alarcon Tomas A, Lin RJ, Yáñez San Segundo L, Shah GL, Cho C, Scordo M, Politikos I, Hayasaka K, Hasegawa Y, Gyurkocza B, Ponce DM, Barker JN, Perales MA, Giralt SA, Jenq RR, Teshima T, Chao NJ, Holler E, Xavier JB, Pamer EG, van den Brink MRM. Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation. N Engl J Med 2020;382:822-34. [PMID: 32101664 DOI: 10.1056/NEJMoa1900623] [Cited by in Crossref: 139] [Cited by in F6Publishing: 87] [Article Influence: 69.5] [Reference Citation Analysis]
3 Heidrich V, Bruno JS, Knebel FH, de Molla VC, Miranda-Silva W, Asprino PF, Tucunduva L, Rocha V, Novis Y, Arrais-Rodrigues C, Fregnani ER, Camargo AA. Dental Biofilm Microbiota Dysbiosis Is Associated With the Risk of Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:692225. [PMID: 34220852 DOI: 10.3389/fimmu.2021.692225] [Reference Citation Analysis]
4 Meedt E, Hiergeist A, Gessner A, Dettmer K, Liebisch G, Ghimire S, Poeck H, Edinger M, Wolff D, Herr W, Holler E, Weber D. Prolonged suppression of butyrate producing bacteria is associated with acute gastrointestinal graft-versus-host disease and transplant related mortality after allogeneic stem cell transplantation. Clin Infect Dis 2021:ciab500. [PMID: 34043764 DOI: 10.1093/cid/ciab500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Kusakabe S, Fukushima K, Yokota T, Hino A, Fujita J, Motooka D, Nakamura S, Shibayama H, Kanakura Y. Enterococcus: A Predictor of Ravaged Microbiota and Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 2020;26:1028-33. [DOI: 10.1016/j.bbmt.2020.01.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Skaarud KJ, Hov JR, Hansen SH, Kummen M, Valeur J, Seljeflot I, Bye A, Paulsen V, Lundin KEA, Trøseid M, Tjønnfjord GE, Iversen PO. Mortality and microbial diversity after allogeneic hematopoietic stem cell transplantation: secondary analysis of a randomized nutritional intervention trial. Sci Rep 2021;11:11593. [PMID: 34078971 DOI: 10.1038/s41598-021-90976-z] [Reference Citation Analysis]
7 Li J, Zhang X, Chen Y, Zheng Q, Zhao M, Jiang H, Dominguez Perles R. A Promising Insight: The Potential Influence and Therapeutic Value of the Gut Microbiota in GI GVHD. Oxidative Medicine and Cellular Longevity 2022;2022:1-13. [DOI: 10.1155/2022/2124627] [Reference Citation Analysis]
8 Nguyen CL, Docampo MD, van den Brink MR, Markey KA. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Curr Opin Genet Dev 2021;66:25-35. [PMID: 33388483 DOI: 10.1016/j.gde.2020.11.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 McMillen KK, Coghlin-Dickson T, Adintori PA. Optimization of nutrition support practices early after hematopoietic cell transplantation. Bone Marrow Transplant 2021;56:314-26. [PMID: 33040076 DOI: 10.1038/s41409-020-01078-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Toenges R, Greinix H, Lawitschka A, Halter J, Baumgartner A, Simon A, Arends J, Jäger P, Middeke M, Hilgendorf I, Klein S, Wagner-Drouet EM, Schmid C, Bug G, Wolff D; German-Austrian-Swiss GVHD consortium. Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers. Clin Nutr 2021;40:1571-7. [PMID: 33744601 DOI: 10.1016/j.clnu.2021.02.030] [Reference Citation Analysis]
11 Szychowiak P, Villageois-Tran K, Patrier J, Timsit JF, Ruppé É. The role of the microbiota in the management of intensive care patients. Ann Intensive Care 2022;12:3. [PMID: 34985651 DOI: 10.1186/s13613-021-00976-5] [Reference Citation Analysis]
12 Li X, Lin Y, Li X, Xu X, Zhao Y, Xu L, Gao Y, Li Y, Tan Y, Qian P, Huang H. Tyrosine supplement ameliorates murine aGVHD by modulation of gut microbiome and metabolome. EBioMedicine 2020;61:103048. [PMID: 33039712 DOI: 10.1016/j.ebiom.2020.103048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
13 Lin D, Hu B, Li P, Zhao Y, Xu Y, Wu D. Roles of the intestinal microbiota and microbial metabolites in acute GVHD. Exp Hematol Oncol 2021;10:49. [PMID: 34706782 DOI: 10.1186/s40164-021-00240-3] [Reference Citation Analysis]
14 Masetti R, Zama D, Leardini D, Muratore E, Turroni S, Brigidi P, Pession A. Microbiome-Derived Metabolites in Allogeneic Hematopoietic Stem Cell Transplantation. Int J Mol Sci 2021;22:1197. [PMID: 33530464 DOI: 10.3390/ijms22031197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Qayed M, Michonneau D, Socié G, Waller EK. Indole derivatives, microbiome and graft versus host disease. Curr Opin Immunol 2021;70:40-7. [PMID: 33647539 DOI: 10.1016/j.coi.2021.02.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Li Y, Honda K. Towards the development of defined microbial therapeutics. Int Immunol 2021:dxab038. [PMID: 34232990 DOI: 10.1093/intimm/dxab038] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Griffin ME, Espinosa J, Becker JL, Luo JD, Carroll TS, Jha JK, Fanger GR, Hang HC. Enterococcus peptidoglycan remodeling promotes checkpoint inhibitor cancer immunotherapy. Science 2021;373:1040-6. [PMID: 34446607 DOI: 10.1126/science.abc9113] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
18 Schubert ML, Rohrbach R, Schmitt M, Stein-Thoeringer CK. The Potential Role of the Intestinal Micromilieu and Individual Microbes in the Immunobiology of Chimeric Antigen Receptor T-Cell Therapy. Front Immunol 2021;12:670286. [PMID: 34135898 DOI: 10.3389/fimmu.2021.670286] [Reference Citation Analysis]
19 Deeg HJ. Individuals, Boundaries, and Graft-versus-Host Disease. Biol Blood Marrow Transplant 2020;26:e309-12. [PMID: 32927076 DOI: 10.1016/j.bbmt.2020.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Fujiwara H. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2021;12:703298. [PMID: 34512627 DOI: 10.3389/fimmu.2021.703298] [Reference Citation Analysis]
21 Blazar BR, Hill GR, Murphy WJ. Dissecting the biology of allogeneic HSCT to enhance the GvT effect whilst minimizing GvHD. Nat Rev Clin Oncol 2020;17:475-92. [PMID: 32313224 DOI: 10.1038/s41571-020-0356-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 9.0] [Reference Citation Analysis]
22 Lyu W, Meng Q, Xiao J, Li J, Wang J, Qiu Z, Song X, Zhu H, Shao C, Chu Y, Zhou Q, Li T, Jean-Pierre R, Yu J, Han Y, Kang Y. Gut lactate-producing bacteria promote CD4 T cell recovery on Anti-retroviral therapy in HIV-infected patients. Comput Struct Biotechnol J 2021;19:2928-37. [PMID: 34141131 DOI: 10.1016/j.csbj.2021.05.021] [Reference Citation Analysis]
23 Wu K, Yuan Y, Yu H, Dai X, Wang S, Sun Z, Wang F, Fei H, Lin Q, Jiang H, Chen T. The gut microbial metabolite trimethylamine N-oxide aggravates GVHD by inducing M1 macrophage polarization in mice. Blood 2020;136:501-15. [PMID: 32291445 DOI: 10.1182/blood.2019003990] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 34.0] [Reference Citation Analysis]
24 Teshima T. Create a healthy diet after transplant! Blood 2020;136:8-9. [PMID: 32614959 DOI: 10.1182/blood.2020006611] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Malard F, Lavelle A, Battipaglia G, Gaugler B, Dulery R, Brissot E, Mediavilla C, Jegou S, Rolhion N, Ledraa T, Mohty R, Sokol H, Mohty M. Impact of gut fungal and bacterial communities on the outcome of allogeneic hematopoietic cell transplantation. Mucosal Immunol 2021;14:1127-32. [PMID: 34282272 DOI: 10.1038/s41385-021-00429-z] [Reference Citation Analysis]
26 Biliński J, Jasiński M, Basak GW. The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease. Biomedicines 2022;10:837. [DOI: 10.3390/biomedicines10040837] [Reference Citation Analysis]
27 Fiorenza S, Turtle CJ. Associations between the Gut Microbiota, Immune Reconstitution, and Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation. Immunometabolism 2021;3:e210004. [PMID: 33552594 DOI: 10.20900/immunometab20210004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
28 Ciernikova S, Kasperova B, Drgona L, Smolkova B, Stevurkova V, Mego M. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation. Blood Rev 2021;48:100790. [PMID: 33573867 DOI: 10.1016/j.blre.2020.100790] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Khuat LT, Le CT, Pai CS, Shields-Cutler RR, Holtan SG, Rashidi A, Parker SL, Knights D, Luna JI, Dunai C, Wang Z, Sturgill IR, Stoffel KM, Merleev AA, More SK, Maverakis E, Raybould HE, Chen M, Canter RJ, Monjazeb AM, Dave M, Ferrara JLM, Levine JE, Longo DL, Abedi M, Blazar BR, Murphy WJ. Obesity induces gut microbiota alterations and augments acute graft-versus-host disease after allogeneic stem cell transplantation. Sci Transl Med 2020;12:eaay7713. [PMID: 33239390 DOI: 10.1126/scitranslmed.aay7713] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
30 Ilett EE, Jørgensen M, Noguera-Julian M, Nørgaard JC, Daugaard G, Helleberg M, Paredes R, Murray DD, Lundgren J, MacPherson C, Reekie J, Sengeløv H. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv 2020;4:5797-809. [PMID: 33232475 DOI: 10.1182/bloodadvances.2020002677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
31 Aizawa K, Peltier D, Matsuki E, Toubai T. How does transfusion-associated graft-versus-host disease compare to hematopoietic cell transplantation-associated graft-versus-host disease? Transfusion and Apheresis Science 2022. [DOI: 10.1016/j.transci.2022.103405] [Reference Citation Analysis]
32 Werner G, Neumann B, Weber RE, Kresken M, Wendt C, Bender JK; VRE study group. Thirty years of VRE in Germany - "expect the unexpected": The view from the National Reference Centre for Staphylococci and Enterococci. Drug Resist Updat 2020;53:100732. [PMID: 33189998 DOI: 10.1016/j.drup.2020.100732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Song Q, Nasri U, Zeng D. Steroid-Refractory Gut Graft-Versus-Host Disease: What We Have Learned From Basic Immunology and Experimental Mouse Model. Front Immunol 2022;13:844271. [DOI: 10.3389/fimmu.2022.844271] [Reference Citation Analysis]
34 Rashidi A, Weisdorf DJ. Microbiota-based approaches to mitigate infectious complications of intensive chemotherapy in patients with acute leukemia. Transl Res 2020;220:167-81. [PMID: 32275896 DOI: 10.1016/j.trsl.2020.03.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
35 Smith M, Dai A, Ghilardi G, Amelsberg KV, Devlin SM, Pajarillo R, Slingerland JB, Beghi S, Herrera PS, Giardina P, Clurman A, Dwomoh E, Armijo G, Gomes ALC, Littmann ER, Schluter J, Fontana E, Taur Y, Park JH, Palomba ML, Halton E, Ruiz J, Jain T, Pennisi M, Afuye AO, Perales MA, Freyer CW, Garfall A, Gier S, Nasta S, Landsburg D, Gerson J, Svoboda J, Cross J, Chong EA, Giralt S, Gill SI, Riviere I, Porter DL, Schuster SJ, Sadelain M, Frey N, Brentjens RJ, June CH, Pamer EG, Peled JU, Facciabene A, van den Brink MRM, Ruella M. Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nat Med 2022. [PMID: 35288695 DOI: 10.1038/s41591-022-01702-9] [Reference Citation Analysis]
36 Ara T, Hashimoto D. Novel Insights Into the Mechanism of GVHD-Induced Tissue Damage. Front Immunol 2021;12:713631. [PMID: 34512636 DOI: 10.3389/fimmu.2021.713631] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
37 Socié G, Kean LS, Zeiser R, Blazar BR. Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host disease. J Clin Invest 2021;131:149296. [PMID: 34101618 DOI: 10.1172/JCI149296] [Reference Citation Analysis]
38 Rolling T, Zhai B, Gjonbalaj M, Tosini N, Yasuma-Mitobe K, Fontana E, Amoretti LA, Wright RJ, Ponce DM, Perales MA, Xavier JB, van den Brink MRM, Markey KA, Peled JU, Taur Y, Hohl TM. Haematopoietic cell transplantation outcomes are linked to intestinal mycobiota dynamics and an expansion of Candida parapsilosis complex species. Nat Microbiol 2021;6:1505-15. [PMID: 34764444 DOI: 10.1038/s41564-021-00989-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Rafei H, Jenq RR. Microbiome-intestine cross talk during acute graft-versus-host disease. Blood 2020;136:401-9. [PMID: 32526029 DOI: 10.1182/blood.2019000950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
40 Vandenhove B, Canti L, Schoemans H, Beguin Y, Baron F, Graux C, Kerre T, Servais S. How to Make an Immune System and a Foreign Host Quickly Cohabit in Peace? The Challenge of Acute Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation. Front Immunol 2020;11:583564. [PMID: 33193397 DOI: 10.3389/fimmu.2020.583564] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Van Lier YF, Van den Brink MRM, Hazenberg MD, Markey KA. The post-hematopoietic cell transplantation microbiome: relationships with transplant outcome and potential therapeutic targets. Haematologica 2021;106:2042-53. [PMID: 33882637 DOI: 10.3324/haematol.2020.270835] [Reference Citation Analysis]
42 Skarbnik AP, Donato ML, Feinman R, Rowley SD, Vesole DH, Goy AH, Munshi PN, Feldman T, Leslie LA, Biran N, Nyirenda T, Fields PA, Descalzi-Montoya D, Zenreich J, Korngold R, Pecora AL. Safety and Efficacy of Consolidation Therapy with Ipilimumab Plus Nivolumab after Autologous Stem Cell Transplantation. Transplant Cell Ther 2021;27:391-403. [PMID: 33965177 DOI: 10.1016/j.jtct.2020.12.026] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Khan N, Lindner S, Gomes ALC, Devlin SM, Shah GL, Sung AD, Sauter CS, Landau HJ, Dahi PB, Perales MA, Chung DJ, Lesokhin AM, Dai A, Clurman A, Slingerland JB, Slingerland AE, Brereton DG, Giardina PA, Maloy M, Armijo GK, Rondon-Clavo C, Fontana E, Bohannon L, Ramalingam S, Bush AT, Lew MV, Messina JA, Littmann E, Taur Y, Jenq RR, Chao NJ, Giralt S, Markey KA, Pamer EG, van den Brink MRM, Peled JU. Fecal microbiota diversity disruption and clinical outcomes after auto-HCT: a multicenter observational study. Blood 2021;137:1527-37. [PMID: 33512409 DOI: 10.1182/blood.2020006923] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
44 Deeg HJ. Chimerism, the Microenvironment and Control of Leukemia. Front Immunol 2021;12:652105. [PMID: 33968052 DOI: 10.3389/fimmu.2021.652105] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Brevi A, Cogrossi LL, Lorenzoni M, Mattorre B, Bellone M. The Insider: Impact of the Gut Microbiota on Cancer Immunity and Response to Therapies in Multiple Myeloma. Front Immunol 2022;13:845422. [DOI: 10.3389/fimmu.2022.845422] [Reference Citation Analysis]
46 Shang T, Guo Y, Li X, Zhou Z, Qi Y, Salahdiin K, Shen R, He S, Wang M, Shi Z, Zhao X, Yang J, Fan G, Wang Y, Gao X, Zhu Y, Feng Y. The combination of four main components in Xuebijing injection improved the preventive effects of Cyclosporin A in acute graft-versus-host disease mice by protecting intestinal microenvironment. Biomedicine & Pharmacotherapy 2022;148:112675. [DOI: 10.1016/j.biopha.2022.112675] [Reference Citation Analysis]
47 Boudry G, Charton E, Le Huerou-Luron I, Ferret-Bernard S, Le Gall S, Even S, Blat S. The Relationship Between Breast Milk Components and the Infant Gut Microbiota. Front Nutr 2021;8:629740. [PMID: 33829032 DOI: 10.3389/fnut.2021.629740] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
48 Kumari R, Palaniyandi S, Hildebrandt GC. The microbiome-the revealing of a long time unbeknownst factor for outcome in murine models of graft-versus-host disease. Bone Marrow Transplant 2021;56:1777-83. [PMID: 34052837 DOI: 10.1038/s41409-021-01325-7] [Reference Citation Analysis]
49 Canfield GS, Duerkop BA. Molecular mechanisms of enterococcal-bacteriophage interactions and implications for human health. Curr Opin Microbiol 2020;56:38-44. [PMID: 32652484 DOI: 10.1016/j.mib.2020.06.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Tourret M, Talvard-Balland N, Lambert M, Ben Youssef G, Chevalier MF, Bohineust A, Yvorra T, Morin F, Azarnoush S, Lantz O, Dalle JH, Caillat-Zucman S. Human MAIT cells are devoid of alloreactive potential: prompting their use as universal cells for adoptive immune therapy. J Immunother Cancer 2021;9:e003123. [PMID: 34615705 DOI: 10.1136/jitc-2021-003123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Xue A, Qian X, Gao X, Wang P, Wang L, Zheng C, Huang Z, Hu W, Shi J, Huang Y. Fecal Microbial Signatures Are Associated With Engraftment Failure Following Umbilical Cord Blood Transplantation in Pediatric Crohn's Disease Patients With IL10RA Deficiency. Front Pharmacol 2020;11:580817. [PMID: 33162889 DOI: 10.3389/fphar.2020.580817] [Reference Citation Analysis]
52 Barnard ND, Leroy F. Children and adults should avoid consuming animal products to reduce risk for chronic disease: YES. Am J Clin Nutr 2020;112:926-30. [PMID: 32889521 DOI: 10.1093/ajcn/nqaa235] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
53 Pan P, Atkinson SN, Taylor B, Zhu H, Zhou D, Flejsierowicz P, Wang LS, Morse M, Liu C, Gunsolus IL, Chen X. Retinoic Acid Signaling Modulates Recipient Gut Barrier Integrity and Microbiota After Allogeneic Hematopoietic Stem Cell Transplantation in Mice. Front Immunol 2021;12:749002. [PMID: 34759928 DOI: 10.3389/fimmu.2021.749002] [Reference Citation Analysis]
54 Turner G, Smith M, Hoeschen AL, Wilson JA, Kennedy J, Abramson M, Cao Q, El Jurdi N, MacMillan ML, Weisdorf DJ, Blazar BR, Khoruts A, Shields-Cutler RR, Knights D, Holtan SG, Rashidi A. Shotgun sequencing of the faecal microbiome to predict response to steroids in patients with lower gastrointestinal acute graft-versus-host disease: An exploratory analysis. Br J Haematol 2021;192:e69-73. [PMID: 33222185 DOI: 10.1111/bjh.17238] [Reference Citation Analysis]
55 Elgarten CW, Li Y, Getz KD, Hemmer M, Huang YV, Hall M, Wang T, Kitko CL, Jagasia MH, Nishihori T, Murthy HS, Hashem H, Cairo MS, Sharma A, Hashmi SK, Askar M, Beitinjaneh A, Kelly MS, Auletta JJ, Badawy SM, Mavers M, Aplenc R, MacMillan ML, Spellman SR, Arora M, Fisher BT. Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease. Transplant Cell Ther 2021;27:177.e1-8. [PMID: 33718896 DOI: 10.1016/j.jtct.2020.10.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Henig I, Yehudai-Ofir D, Zuckerman T. The clinical role of the gut microbiome and fecal microbiota transplantation in allogeneic stem cell transplantation. Haematologica 2021;106:933-46. [PMID: 33241674 DOI: 10.3324/haematol.2020.247395] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
57 Teshima T, Hill GR. The Pathophysiology and Treatment of Graft-Versus-Host Disease: Lessons Learnt From Animal Models. Front Immunol 2021;12:715424. [PMID: 34489966 DOI: 10.3389/fimmu.2021.715424] [Reference Citation Analysis]
58 Ingham AC, Kielsen K, Mordhorst H, Ifversen M, Aarestrup FM, Müller KG, Pamp SJ. Microbiota long-term dynamics and prediction of acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Microbiome 2021;9:148. [PMID: 34183060 DOI: 10.1186/s40168-021-01100-2] [Reference Citation Analysis]
59 Zitvogel L, Kroemer G. Immunostimulatory gut bacteria. Science 2019;366:1077-8. [PMID: 31780546 DOI: 10.1126/science.aaz7595] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
60 Gao MG, Hong Y, Zhao XY, Pan XA, Sun YQ, Kong J, Wang ZD, Wang FR, Wang JZ, Yan CH, Wang Y, Huang XJ, Zhao XS. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation. Front Immunol 2021;12:720354. [PMID: 34539656 DOI: 10.3389/fimmu.2021.720354] [Reference Citation Analysis]
61 Zhou Z, Shang T, Li X, Zhu H, Qi YB, Zhao X, Chen X, Shi ZX, Pan G, Wang YF, Fan G, Gao X, Zhu Y, Feng Y. Protecting Intestinal Microenvironment Alleviates Acute Graft-Versus-Host Disease. Front Physiol 2020;11:608279. [PMID: 33643058 DOI: 10.3389/fphys.2020.608279] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
62 Liao C, Taylor BP, Ceccarani C, Fontana E, Amoretti LA, Wright RJ, Gomes ALC, Peled JU, Taur Y, Perales MA, van den Brink MRM, Littmann E, Pamer EG, Schluter J, Xavier JB. Compilation of longitudinal microbiota data and hospitalome from hematopoietic cell transplantation patients. Sci Data 2021;8:71. [PMID: 33654104 DOI: 10.1038/s41597-021-00860-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
63 Tyszka M, Biliński J, Basak GW. Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting. J Clin Med 2021;10:2508. [PMID: 34204044 DOI: 10.3390/jcm10112508] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
64 Sato S, Shimizu E, He J, Ogawa M, Asai K, Yazu H, Rusch R, Yamane M, Yang F, Fukuda S, Kawakami Y, Tsubota K, Ogawa Y. Positive Effects of Oral Antibiotic Administration in Murine Chronic Graft-Versus-Host Disease. Int J Mol Sci 2021;22:3745. [PMID: 33916809 DOI: 10.3390/ijms22073745] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Zeinali LI, Giuliano S, Lakshminrusimha S, Underwood MA. Intestinal Dysbiosis in the Infant and the Future of Lacto-Engineering to Shape the Developing Intestinal Microbiome. Clin Ther 2021:S0149-2918(21)00459-8. [PMID: 34922744 DOI: 10.1016/j.clinthera.2021.11.005] [Reference Citation Analysis]
66 Hong T, Wang R, Wang X, Yang S, Wang W, Gao Q, Zhang X. Interplay Between the Intestinal Microbiota and Acute Graft-Versus-Host Disease: Experimental Evidence and Clinical Significance. Front Immunol 2021;12:644982. [PMID: 33815399 DOI: 10.3389/fimmu.2021.644982] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Kullberg RFJ, Wiersinga WJ, Haak BW. Gut microbiota and sepsis: from pathogenesis to novel treatments. Curr Opin Gastroenterol 2021;37:578-85. [PMID: 34419965 DOI: 10.1097/MOG.0000000000000781] [Reference Citation Analysis]
68 Canfield GS, Chatterjee A, Espinosa J, Mangalea MR, Sheriff EK, Keidan M, McBride SW, McCollister BD, Hang HC, Duerkop BA. Lytic bacteriophages facilitate antibiotic sensitization of Enterococcus faecium. Antimicrob Agents Chemother 2021:AAC. [PMID: 33649110 DOI: 10.1128/AAC.00143-21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
69 Kaźmierczak-Siedlecka K, Skonieczna-Żydecka K, Biliński J, Roviello G, Iannone LF, Atzeni A, Sobocki BK, Połom K. Gut Microbiome Modulation and Faecal Microbiota Transplantation Following Allogenic Hematopoietic Stem Cell Transplantation. Cancers (Basel) 2021;13:4665. [PMID: 34572894 DOI: 10.3390/cancers13184665] [Reference Citation Analysis]
70 Ouyang J, Isnard S, Lin J, Fombuena B, Peng X, Nair Parvathy S, Chen Y, Silverman MS, Routy JP. Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection. Front Med (Lausanne) 2020;7:421. [PMID: 32850913 DOI: 10.3389/fmed.2020.00421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
71 Shouval R, Eshel A, Dubovski B, Kuperman AA, Danylesko I, Fein JA, Fried S, Geva M, Kouniavski E, Neuman H, Armon-Omer A, Shahien R, Muller E, Noecker C, Borenstein E, Louzoun Y, Nagler A, Koren O. Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation. Blood Adv 2020;4:2912-7. [PMID: 32598476 DOI: 10.1182/bloodadvances.2020001827] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
72 Le Bastard Q, Chevallier P, Montassier E. Gut microbiome in allogeneic hematopoietic stem cell transplantation and specific changes associated with acute graft vs host disease. World J Gastroenterol 2021; 27(45): 7792-7800 [PMID: 34963742 DOI: 10.3748/wjg.v27.i45.7792] [Reference Citation Analysis]
73 Alexander T, Snowden JA, Burman J, Chang HD, Del Papa N, Farge D, Lindsay JO, Malard F, Muraro PA, Nitti R, Salas A, Sharrack B, Mohty M, Greco R. Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMT. Front Oncol 2021;11:722436. [PMID: 34745944 DOI: 10.3389/fonc.2021.722436] [Reference Citation Analysis]
74 Costantini C, Nunzi E, Spolzino A, Palmieri M, Renga G, Zelante T, Englmaier L, Coufalikova K, Spáčil Z, Borghi M, Bellet MM, Acerbi E, Puccetti M, Giovagnoli S, Spaccapelo R, Talesa VN, Lomurno G, Merli F, Facchini L, Spadea A, Melillo L, Codeluppi K, Marchesi F, Marchesini G, Valente D, Dragonetti G, Nadali G, Pagano L, Aversa F, Romani L. Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic Patients. Infect Immun 2021;89:e0010521. [PMID: 33782152 DOI: 10.1128/IAI.00105-21] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
75 Malard F, Vekhoff A, Lapusan S, Isnard F, D'incan-Corda E, Rey J, Saillard C, Thomas X, Ducastelle-Lepretre S, Paubelle E, Larcher MV, Rocher C, Recher C, Tavitian S, Bertoli S, Michallet AS, Gilis L, Peterlin P, Chevallier P, Nguyen S, Plantamura E, Boucinha L, Gasc C, Michallet M, Dore J, Legrand O, Mohty M. Gut microbiota diversity after autologous fecal microbiota transfer in acute myeloid leukemia patients. Nat Commun 2021;12:3084. [PMID: 34035290 DOI: 10.1038/s41467-021-23376-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
76 Andermann TM, Fouladi F, Tamburini FB, Sahaf B, Tkachenko E, Greene C, Buckley MT, Brooks EF, Hedlin H, Arai S, Mackall CL, Miklos D, Negrin RS, Fodor AA, Rezvani AR, Bhatt AS. A Fructo-Oligosaccharide Prebiotic Is Well Tolerated in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Phase I Dose-Escalation Trial. Transplant Cell Ther 2021:S2666-6367(21)01074-5. [PMID: 34274493 DOI: 10.1016/j.jtct.2021.07.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
77 Devaux CA, Million M, Raoult D. The Butyrogenic and Lactic Bacteria of the Gut Microbiota Determine the Outcome of Allogenic Hematopoietic Cell Transplant. Front Microbiol 2020;11:1642. [PMID: 32793150 DOI: 10.3389/fmicb.2020.01642] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
78 Uribe-Herranz M, Klein-González N, Rodríguez-Lobato LG, Juan M, de Larrea CF. Gut Microbiota Influence in Hematological Malignancies: From Genesis to Cure. Int J Mol Sci 2021;22:1026. [PMID: 33498529 DOI: 10.3390/ijms22031026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
79 Chang CC, Hayase E, Jenq RR. The role of microbiota in allogeneic hematopoietic stem cell transplantation. Expert Opin Biol Ther 2021;21:1121-31. [PMID: 33412949 DOI: 10.1080/14712598.2021.1872541] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Dongari-Bagtzoglou A. Risky Business: Oropharyngeal Bacteria Linked to Risk for Invasive Fungal Infection. Infect Immun 2021;89:e0017421. [PMID: 33972370 DOI: 10.1128/IAI.00174-21] [Reference Citation Analysis]
81 Lindner S, Peled JU. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Curr Opin Hematol 2020;27:360-7. [PMID: 33003084 DOI: 10.1097/MOH.0000000000000616] [Reference Citation Analysis]
82 Ma T, Chen Y, Li LJ, Zhang LS. Opportunities and Challenges for Gut Microbiota in Acute Leukemia. Front Oncol 2021;11:692951. [PMID: 34307157 DOI: 10.3389/fonc.2021.692951] [Reference Citation Analysis]
83 [DOI: 10.1101/2020.08.20.256263] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
84 Masetti R, Muratore E, Leardini D, Zama D, Turroni S, Brigidi P, Esposito S, Pession A. Gut microbiome in pediatric acute leukemia: from predisposition to cure. Blood Adv 2021;5:4619-29. [PMID: 34610115 DOI: 10.1182/bloodadvances.2021005129] [Reference Citation Analysis]
85 Kaur J, Cao X, Abutaleb NS, Elkashif A, Graboski AL, Krabill AD, AbdelKhalek AH, An W, Bhardwaj A, Seleem MN, Flaherty DP. Optimization of Acetazolamide-Based Scaffold as Potent Inhibitors of Vancomycin-Resistant Enterococcus. J Med Chem 2020;63:9540-62. [PMID: 32787141 DOI: 10.1021/acs.jmedchem.0c00734] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]